HHRI Media Coverage

HHRI Media Coverage

2019

February

Hennepin County jail and workhouse to tackle opioid addiction deaths head on - StarTribune 2/2/2019
A study revealed that large numbers of the inmates overdose and die shortly after they are released from custody. Dr. Tyler Winkelman, a health policy expert at Hennepin Healthcare is one of the authors of the study.” Dr. Gavin Bart, director of addiction medicine at Hennepin Healthcare is one of the advisers on the study.
 
Read the StarTribune Story
 
 
U of M, Hennepin Healthcare study gives hope to those told they would never walk again - FOX9 2/1/19

New research by a local team of doctors is proving to be life-changing for people paralyzed by spinal cord injuries. It’s giving hope to thousands who previously thought they would never walk again. It took the University of Minnesota and Hennepin Healthcare two years to get through all of the paperwork, including grant approvals. It’s especially unique because doctors are studying patients who have been paralyzed for multiple years.

Read and view the story on FOX9

University of Minnesota researchers make possible breakthrough in paralysis treatment - Bring Me the News 2/1/19
They've been able to restore some function in patients with devastating spinal cord injuries.
 
Previously, it's been possible to restore some level of function in young and healthy patients who suffered a devastating spinal cord injury within a few years of it happening. But as part of the E-STAND clinical trial, Dr. David Darrow, a neurosurgery resident at the medical school and Hennepin Healthcare, broadened the scope of patients who can qualify for epidural spinal cord stimulation (ESCS).
 

January

Restoring movement and autonomic function in patients with complete paralysis - Science Daily 1/31/19
There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients within a few years of injury. Now, researchers show spinal cord stimulation can immediately restore some voluntary movement and autonomic functions such as cardiovascular, bowel, and bladder years after a paralyzing injury without any significant rehabilitation.
 
 
 
Flu May Be a Factor in Many Kidney Failure Deaths - US News & World Report 1/28/19

Seasonal flu and other respiratory infections may be especially dangerous for kidney failure patients, researchers say. A new study found that influenza-like illnesses likely contribute to more than 1,000 deaths among kidney failure patients in the United States each year. These illnesses include potentially serious respiratory tract infections caused by flu and other viruses. For the study, David Gilbertson, co-director of the Chronic Disease Research Group at Hennepin Healthcare Research Institute in Minneapolis, and his colleagues reviewed 14 years of federal data.

Read the story in US News & World Report

Seasonal influenza plays a role in the deaths of many kidney failure patients - Medical X Press 1/24/19

In patients with kidney failure, influenza-like illness (ILI) likely contributes to more than 1,000 deaths per year. The finding, which comes from a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), points to the importance of protection against, surveillance of, and, where possible, treatment of such infections in patients with kidney dysfunction.

The extent to which ILI contributes to mortality in patients with ESRD is unclear. To investigate, David Gilbertson, Ph.D. (Hennepin Healthcare Research Institute and the University of Minnesota) and his colleagues analyzed data from the Centers for Disease Control and Prevention Outpatient ILI Surveillance Network and the Centers for Medicare & Medicaid Services ESRD database from 2000-2013.

 

Read the Medical X Press article

2018

November

Another drug crisis: Methamphetamine use by pregnant women - MPR News 11/29/18

Kristen Philman had already been using heroin and prescription painkillers for several years when, one day in 2014, a relative offered her some methamphetamine, a chemical cousin to the stimulant amphetamine. "I didn't have any heroin at the time," says Philman, a resident of Littleton, Colo. "I thought, 'Oh this might make me feel better.' "It did, she says. Soon, she was using both heroin and methamphetamine on a regular basis.

Read the story on mprnews.org

Listen to the story

How to beat burnout: 7 signs physicians should know - AMA Wire 11/27/18

Committed to making physician burnout a thing of the past, the AMA has studied, and is currently addressing, issues causing and fueling physician burnout—including time constraints, technology and regulations—to better understand the challenges physicians face.

Mark Linzer, MD, director of the division of general internal medicine at Hennepin County Medical Center in Minneapolis, has long studied physician burnout.

“Burnout doesn’t have to be highly expensive to fix,” said Dr. Linzer, director of the HCMC Center for Patient and Provider Experience. “Preventing burnout can actually save money in the long run on recruiting and training new practice staff.”  

Read the AMA Wire story

Overshadowed by opioids, meth is back with a vengeance - NBC news 11/27/18

The number of people hospitalized because of amphetamine use is skyrocketing in the United States, but the resurgence of the drug has largely been overshadowed by the nation’s intense focus on opioids.

Amphetamine-related hospitalizations jumped by about 245 percent from 2008 to 2015, according to a study published last month in the Journal of the American Medical Association. That dwarfs the rise in hospitalizations from other drugs, such as opioids, which were up by about 46 percent. The most significant increases were in Western states.

The JAMA study, based on hospital discharge data, found that the cost of amphetamine-related hospitalizations had jumped from $436 million in 2003 to nearly $2.2 billion by 2015. Medicaid was the primary payer.

Read the NBC News story

Out of prison, but struggling for health care - StarTribune 11/26/18

For those with a substance use disorder, the risk of death from an overdose in the two weeks after leaving prison is 10 times higher than in the general population, said Dr. Tyler Winkelman of the Minneapolis-based Hennepin Healthcare, who researches health
issues in the criminal justice system.

Read the StarTribune story

Overshadowed by opioids, Meth is back and hospitalizations surge - ABC News 11/26/18

Because there has been so much attention on opioids, “we have not been properly keeping tabs on other substance use trends as robustly as we should,” said study author Dr. Tyler Winkelman, a physician at Hennepin Healthcare in Minneapolis.

View the story on ABC

Overshadowed By Opioids, Meth Is Back And Hospitalizations Surge - Kaiser Health News 11/26/18

The number of people hospitalized because of amphetamine use is skyrocketing in the United States, but the resurgence of the drug largely has been overshadowed by the nation’s intense focus on opioids.

Read the KHN article

Opioids Are In the Spotlight. But Meth Hospitalizations Are Surging - TIME 11/21/18

The number of people hospitalized because of amphetamine use is skyrocketing in the United States, but the resurgence of the drug largely has been overshadowed by the nation’s intense focus on opioids. Amphetamine-related hospitalizations jumped by about 245% from 2008 to 2015, according to a recent study in the Journal of the American Medical Association.

Read the story on TIME

An estimated 30,000 people died from opioid overdoses in the U.S. in 2017. With so many people being affected what is being done to treat addiction? - MPR 11/14/18

11 a.m. – MPR News at 11
An estimated 30,000 people died from opioid overdoses in the U.S. in 2017. With so many people being affected what is being done to treat addiction?

Guests: Marco Pravetoni, associate professor, Department of Pharmacology, senior investigator at the Minneapolis Medical Research Foundation in the Hennepin County Medical Center; Joseph Lee, M.D., medical director, Hazelden Betty Ford Foundation Youth Continuum.

Giving Back: FoodRx program embraces Food as Medicine - StarTribune 11/7/18

Dr. Diana Cutts, a pediatrician from Hennepin Healthcare, part of the FoodRx program, said the dilemmas poor families face are real and wrenching.

Read the StarTribune story

October

At HCMC, doctors pursue a new way to treat opioid addiction - StarTribune 10/23/18

“One of the problems with addiction treatment is that it’s generally been put on the patient to take care of on their own. We wouldn’t tell someone with cancer or heart disease to go make an appointment and hope they get better,” said Dr. James Miner, chief of emergency medicine at HCMC. “The goal now is to get people started on treatment and on the road to recovery right away.”

Read the StarTribune story

Aspirin for people over 70? New science right here - Healthy Matters podcast and blog 10/21/18

Aspirin YES or NO?  Dr. Anne Murray,  a geriatrician and the US Principal Investigator for the ASPREE study is Dr. David Hilden's guest on Healthy Matters on WCCO Radio, October 21, 2018. 

Read the Healthy Matters blog

Listen to the Healthy Matters podcast

September

Aspirin studies no cause for panic, Twin Cities doctors say - StarTribune 9/28/18

Aspirin has been a top topic all week — in clinics, living rooms and offices — because
three studies challenged the guidance for certain older adults taking it daily.

The latest study, known as ASPREE, followed 15,000 healthy adults ages 70 and older
over five years. It found that those taking aspirin had no greater protection from
disabilities or heart attacks but did have higher drug-related risks of internal bleeding.

Margolis and Bloomington-based HealthPartners enrolled 250 adults. Minneapolis-based
Hennepin Healthcare led the U.S. arm of the study, which was based in Australia.

Dr. Anne Murray, the Hennepin geriatrician who led the research, has been flooded with
questions about her results: “It’s been a combination of patients and colleagues, some of
whom are taking aspirin themselves.”

Read the StarTribune story

An Aspirin a Day for Older People Doesn’t Prolong Healthy Lifespan - NIH Director's Blog 9/25/18

Many older people who’ve survived a heart attack or stroke take low-dose aspirin every day to help prevent further cardiovascular problems [1]. There is compelling evidence that this works. But should perfectly healthy older folks follow suit?

Most of us would have guessed “yes”—but the answer appears to be “no” when you consider the latest scientific evidence.  Recently, a large, international study of older people without a history of cardiovascular disease found that those who took a low-dose aspirin daily over more than 4 years weren’t any healthier than those who didn’t. What’s more, there were some unexpected indications that low-dose aspirin might even boost the risk of death.

The long-awaited results of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, partly funded by NIH, were presented in three papers just published in the New England Journal of Medicine [2,3,4]. It’s the largest primary prevention study ever undertaken in healthy older people.

To take a closer look, a research team led by John McNeil, Monash University, Melbourne, Australia, and Anne Murray, Hennepin Healthcare Research Institute, Minneapolis, launched the ASPREE trial in 2010.

 

Read the NIH Director's Blog

An aspirin a day? Not necessarily - StarTribune 9/18/18

A major international study led in part by a Minnesota physician has found that healthy
people over age 70 got no preventive benefit from aspirin and were at greater risk for
harm such as stomach bleeding. It's the third major study this year to reach a similar
conclusion.

"We hope this shifts the paradigm for people 70 and older who are considering taking
aspirin," said Dr. Anne Murray, a geriatrician at Hennepin Healthcare in Minneapolis
who led the research along with Dr. John McNeil in Australia.

Read the StarTribune story

Daily aspirin may do more harm than good for healthy older adults, study finds - MinnPost 9/18/18

Many heart-healthy older people take a daily baby aspirin out of a belief that it will help prevent a
heart attack or stroke. A major new study, published online Sunday in three articles in the New England Journal of Medicine (NEJM), now calls that common practice into serious question. It found that for older people with no history of heart attack, stroke or congestive heart failure taking a daily aspirin might do more harm than good.

”We found there was no discernible benefit of aspirin on prolonging independent, healthy life for the elderly,” Dr. Anne Murray, one of the authors of the study and an epidemiologist and geriatrician at Hennepin Healthcare in Minneapolis, told National Public Radio (NPR) reporter Rob Stein.

Read the MinnPost story

Baby-aspirin risks overwhelm benefits in healthy elderly - Reuters - FOX NEWS 9/17/18

In healthy elderly people who never had a heart attack, the widespread practice of taking a baby aspirin every day may do more harm than good, according to a U.S.-Australian study of more than 19,000 volunteers.

The results - which show that risks of major bleeding in low-dose aspirin users overwhelm any heart benefits - were reported online in the New England Journal of Medicine and presented Sunday at the European Respiratory Society International Congress in Paris.

Read the Reuters story on FOX NEWS

Today Show - Twitter 9/17/18
Dr. Mehmet Oz - Twitter 9/17/18
With daily low-dose aspirin use, risks may outweigh benefits for older adults - CNN 9/17/18

It's one of the most well-known tenets of modern medicine: An aspirin a day keeps the doctor away. But according to a trio of studies published Sunday in the New England Journal of Medicine, a daily low-dose aspirin regimen provides no significant health benefits for healthy older adults. Instead, it may cause them serious harm.

Read / Watch the Story on CNN

CNN's Dr. Sanjay Gupta - Twitter 9/17/18
Low-Dose Aspirin Late in Life? Healthy People May Not Need It - The New York Times 9/16/18

Should older people in good health start taking aspirin to prevent heart attacks, strokes,
dementia and cancer?

No, according to a study of more than 19,000 people, including whites 70 and older, and
blacks and Hispanics 65 and older. They took low-dose aspirin — 100 milligrams — or a
placebo every day for a median of 4.7 years. Aspirin did not help them — and may have
done harm.

Read the story in The New York Times

Daily Aspirin Could Be Harmful For Healthy, Older Adults, New Studies Find - NBC Nightly News 9/16/18

Researchers found that taking low dose aspirin did not prevent heart attacks or cardiovascular disease in healthy people over 70, and the daily pill increased the risk of serious health complications like stomach and brain bleeding.

Watch the NBC Nightly News Story

ASPREE: No Benefit of Aspirin in Primary Prevention - Medscape 9/16/18

The possible utility of aspirin for primary prevention has taken another blow with new results showing no benefit of treatment in extending disability-free survival, a novel endpoint that combines all-cause death, dementia, or physical disability, among healthy elderly persons.

A second report showed no significant reduction in cardiovascular disease but a significantly higher risk for major hemorrhage, and a third analysis showed higher all-cause mortality with aspirin therapy, mostly attributed to increased cancer risk, although the researchers urge caution in interpreting this latter finding.  

The results, from the Aspirin in Reducing Events in the Elderly (ASPREE) trial, were published online September 16 in three separate papers in the New England Journal of Medicine (NEJM).  

Read the Medscape article

ASPREE: Aspirin Bombs Again for Primary Prevention - MedPage Today 9/16/18

Daily aspirin not only failed to help generally healthy older individuals reduce their risk of disability-free survival and cardiovascular disease in the placebo-controlled ASPREE trial, it also appeared to raise overall mortality and particularly death from cancer.

Read the story on MedPage Today

Study: A Daily Baby Aspirin Has No Benefit For Healthy Older People - NPR 9/16/18

Many healthy Americans take a baby aspirin every day to reduce their risk of having a heart attack, getting cancer and even possibly dementia. But is it really a good idea?

Results released Sunday from a major study of low-dose aspirin contain a disappointing answer for older, otherwise healthy people.

"We found there was no discernible benefit of aspirin on prolonging independent, healthy life for the elderly," says Anne Murray, a geriatrician and epidemiologist at Hennepin Healthcare in Minneapolis, who helped lead the study.

Read the NPR story

Listen to the NPR interview with Dr. Murray

Low-Dose Aspirin Offers No Overall Benefit for Healthy Older People, Research Says - Washington Post 9/16/18

A regimen of low-dose aspirin “offers healthy, older people no benefit in staving off cardiovascular disease, dementia or disability and increases their risk of bleeding in the digestive tract and brain, according to a large study released Sunday.” The article says that research indicates “a regimen of low-dose aspirin offers healthy, older people no benefit in staving off cardiovascular disease, dementia or disability and increases their risk of bleeding in the digestive tract and brain.” The findings were published in three articles in the New England Journal of Medicine. In a news release, Richard J. Hodes, Director of the National Institute on Aging, said, “Clinical guidelines note the benefits of aspirin for preventing heart attacks and strokes in persons with vascular conditions such as coronary artery disease.” Hodes added, “The concern has been uncertainty about whether aspirin is beneficial for otherwise healthy older people without those conditions.” To view the NEJM articles, click here, here, and here.

Read the Washington Post story

Baby-aspirin risks overwhelm benefits in healthy elderly - Reuters 9/16/18

Researchers determined that after nearly five years in treatment, participants’ “rate of heart disease was not significantly lower,” although the “rate of major bleeding with daily aspirin use was 3.8 percent, versus 2.8 percent with placebo.” Lead author Dr. John J. McNeil of Monash University commented, “Essentially, we could not identify any subgroup in whom aspirin was beneficial in preserving good health.”

Read the Reuters article

Daily aspirin may be harmful for healthy older adults, large study finds - NBC News 9/16/18

For decades, a daily dose of aspirin has been widely considered a way to protect healthy people from cardiovascular disease and even cancer. But a large international study finds that even at low doses, long-term use of aspirin may be harmful — without providing any benefit — for older people who have not already had a heart attack or stroke.

The new research reinforces the results of a study published in late August, which found that daily low-dose aspirin was too risky to be prescribed to patients at moderate risk of heart disease. In the August study and the new one, researchers found a significant risk of internal gastric bleeding caused by the medication, which thins the blood. Older patients experienced no health benefits from taking aspirin, according to the new report, published Sunday in the New England Journal of Medicine.

“We knew there would an increased risk of bleeding with aspirin, because there has always been," said study coauthor Dr. Anne Murray, a geriatrician and epidemiologist at the Hennepin Healthcare Research Institute and the University of Minnesota, Minneapolis. "But not only did it not decrease risk of disability or death, it did not decrease the risk of heart attack and stroke, and there was an increase in the rate of death."

Read / Watch the NBC News story

Is Daily Low-Dose Aspirin Really Worth It for Seniors? - HealthDay 9/16/18

There's disappointing news for seniors: A new trial shows that taking daily low-dose aspirin doesn't prolong healthy, independent living in otherwise healthy people aged 70 and older.

Aspirin has long been recommended for middle-aged folks with a history of heart disease, to prevent future heart attacks or strokes.

Researchers had hoped that aspirin's specific effects might help folks ease gracefully into their old age.

"The thinking was the double action of blood thinning and anti-inflammation might decrease the risk of dementia and disability," explained senior researcher Dr. Anne Murray, director of the Berman Center for Outcomes and Clinical Research at Hennepin Healthcare in Minneapolis.

But a major new clinical trial has concluded that daily aspirin does not prolong disability-free survival in the elderly.

Read the story on HealthDay

Daily aspirin use in older adults can spark adverse outcomes - Modern Healthcare 9/16/18

Another clinical trial has added more evidence against the fairly common practice of prescribing aspirin to healthy older adults in order to prevent the onset of cardiovascular disease.

The clinical trial, which ran from 2010 to 2014 and included 19,114 individuals 70 years and older from the U.S. and Australia, found that a low daily dose of aspirin only marginally decreased a patient's risk of cardiovascular disease while significantly increasing the patient's risk of hemorrhage. Additionally, higher death rates were reported among those taking aspirin daily although the researchers are skeptical about how much weight to put on the finding since it's an unexpected outcome compared to similar studies.

"For a healthy person 70 and older who doesn't have an indication to be on aspirin, there really is no benefit to be on aspirin, in fact, the risks appear to outweigh the benefits in terms of increase bleeding risk and the potential for increased mortality risk," said Dr. Anne Murphy, co-principal investigator of the trial and director of the Berman Center for Outcomes and Clinical Research.

Read the Modern Healthcare article

Daily aspirin unlikely to help healthy older people live longer, study finds - The Guardian (UK) 9/16/18

Millions of healthy people who take aspirin to ward off illness in old age are unlikely to
benefit from the drug, a trial has found.

While a daily dose of the blood-thinning medicine can protect older people who have
previously experienced heart attacks, strokes and angina, researchers found the drug did
not extend the lifespan of healthy people over the age of 70.

Doctors in Australia and the US enrolled more than 19,000 healthy people, mostly aged
over 70, for the trial. Half the participants were asked to take 100mg of aspirin each day,
while the rest took a placebo pill.

Read The Guardian (UK) article

July

With More Opioid Use, People Are More Likely To Get Caught Up In The Justice System - NPR 7/6/18

People addicted to prescription opioids or heroin are far more likely to have run-ins with the
law than those who don't use opioids, according to a new study published Friday in JAMA
Network Open.

"There have been reports that jails and prisons are bearing the brunt of the opioid epidemic,
but we didn't know nationally how many people who use opioids are involved in the criminal
justice system," says Tyler Winkelman, a clinician-investigator at Hennepin Healthcare in Minneapolis, and lead author of the study.

Read the NPR story

May

Integrated Care Affects Healthcare Use Among Vulnerable Adults - Managed Healthcare Executive 5/22/18

Providing integrated medical care and social support services led to increased use of
primary care among vulnerable adults who were enrolled in a Medicaid accountable
care organization (ACO), according to two studies published in Medical Care Research
and Review

One study used Medicaid claims data for about 90,000 enrollees to compare the use of
medical services by Hennepin Health (Hennepin County, MN) ACO enrollees to non-ACO
Medicaid enrollees in the same geographic area. 

The second study used interview data from 35 Hennepin Health members enrolled for two or more years during the study period.

Read the story in Managed Healthcare Executive 

Researchers are working on an opioid vaccine to help addicts avoid overdosing - CircaNews 5/1/18

People take a vaccine for the flu every year to avoid getting sick, but researchers across the country are working on a vaccine to help opioid addicts avoid overdosing.

"Ultimately, I think it can save lives. A vaccine like this could offer sort of long lasting protection," said senior investigator at the Minneapolis Medical Research Foundation (MMRF) Dr. Marco Pravetoni. Pravetoni and his team at MMRF have been working on a vaccine for the last 10 years, with their primary focus on the prescription painkiller oxycontin.

Read the CircaNews story

input search string and hit enter